As of May 21
| +0.25 / +0.92%|
The 10 analysts offering 12-month price forecasts for Medicines Co have a median target of 32.00, with a high estimate of 42.00 and a low estimate of 22.00. The median estimate represents a +16.45% increase from the last price of 27.48.
The current consensus among 11 polled investment analysts is to Hold stock in Medicines Co. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.